Status:
COMPLETED
A Comparison of the Safety and Comfort of AC-170
Lead Sponsor:
Aciex Therapeutics, Inc.
Conditions:
Normal Ocular Health
Eligibility:
All Genders
18+ years
Phase:
PHASE1
Brief Summary
The purpose of this study is to evaluate the safety and comfort of AC-170 compared to a placebo.
Eligibility Criteria
Inclusion
- Able and willing to avoid the use of ocular medications or topical ocular preparations within protocol specific time period.
Exclusion
- Known contraindications or sensitivities to the study medication or its components.
- Any ocular condition that, in the opinion of the investigator, could affect the subjects safety or trial parameters.
- Use of disallowed medications during the period indicated prior to the study enrollment or during the study.
Key Trial Info
Start Date :
December 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2011
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT01495338
Start Date
December 1 2011
End Date
December 1 2011
Last Update
September 14 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Andover Eye Associates
Andover, Massachusetts, United States, 01810